Works about EPIRUBICIN

Results: 518
    1
    2

    Assessment of early treatment response to neoadjuvant chemotherapy in breast cancer using non-mono-exponential diffusion models: a feasibility study comparing the baseline and mid-treatment MRI examinations.

    Published in:
    2017
    By:
    • Bedair, Reem;
    • Priest, Andrew;
    • Patterson, Andrew;
    • McLean, Mary;
    • Graves, Martin;
    • Manavaki, Roido;
    • Gill, Andrew;
    • Abeyakoon, Oshaani;
    • Griffiths, John;
    • Gilbert, Fiona;
    • Priest, Andrew N;
    • Patterson, Andrew J;
    • McLean, Mary A;
    • Graves, Martin J;
    • Gill, Andrew B;
    • Griffiths, John R;
    • Gilbert, Fiona J
    Publication type:
    journal article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34.

    Published in:
    2021
    By:
    • Bartsch, Rupert;
    • Singer, Christian F.;
    • Pfeiler, Georg;
    • Hubalek, Michael;
    • Stoeger, Herbert;
    • Pichler, Angelika;
    • Petru, Edgar;
    • Bjelic-Radisic, Vesna;
    • Greil, Richard;
    • Rudas, Margaretha;
    • Muy-Kheng, Tea Maria;
    • Wette, Viktor;
    • Petzer, Andreas L.;
    • Sevelda, Paul;
    • Egle, Daniel;
    • Dubsky, Peter C.;
    • Filipits, Martin;
    • Fitzal, Florian;
    • Exner, Ruth;
    • Jakesz, Raimund
    Publication type:
    journal article
    38
    39
    40

    Immune gene expression and response to chemotherapy in advanced breast cancer.

    Published in:
    2018
    By:
    • Foukakis, Theodoros;
    • Lövrot, John;
    • Matikas, Alexios;
    • Zerdes, Ioannis;
    • Lorent, Julie;
    • Tobin, Nick;
    • Suzuki, Chikako;
    • Brage, Suzanne Egyházi;
    • Carlsson, Lena;
    • Einbeigi, Zakaria;
    • Linderholm, Barbro;
    • Loman, Niklas;
    • Malmberg, Martin;
    • Fernö, Mårten;
    • Skoog, Lambert;
    • Bergh, Jonas;
    • Hatschek, Thomas;
    • Lövrot, John;
    • Brage, Suzanne Egyházi;
    • Fernö, Mårten
    Publication type:
    journal article
    41
    42
    43
    44
    45

    Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials.

    Published in:
    British Journal of Cancer, 2012, v. 107, n. 8, p. 1257, doi. 10.1038/bjc.2012.370
    By:
    • Earl, H. M.;
    • Hiller, L.;
    • Dunn, J. A.;
    • Vallier, A.-L.;
    • Bowden, S. J.;
    • Jordan, S. D.;
    • Blows, F.;
    • Munro, A.;
    • Bathers, S.;
    • Grieve, R.;
    • Spooner, D. A.;
    • Agrawal, R.;
    • Fernando, I.;
    • Brunt, A. M.;
    • O'Reilly, S. M.;
    • Crawford, S. M.;
    • Rea, D. W.;
    • Simmonds, P.;
    • Mansi, J. L.;
    • Stanley, A.
    Publication type:
    Article
    46
    47
    48
    49

    Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy.

    Published in:
    2017
    By:
    • Ludovini, Vienna;
    • Antognelli, Cinzia;
    • Rulli, Antonio;
    • Foglietta, Jennifer;
    • Pistola, Lorenza;
    • Eliana, Rulli;
    • Floriani, Irene;
    • Nocentini, Giuseppe;
    • Romana Tofanetti, Francesca;
    • Piattoni, Simonetta;
    • Minenza, Elisa;
    • Talesa, Vincenzo Nicola;
    • Sidoni, Angelo;
    • Tonato, Maurizio;
    • Crinò, Lucio;
    • Gori, Stefania;
    • Tofanetti, Francesca Romana
    Publication type:
    journal article
    50